High-glucose-altered endothelial cell function involves both disruption of cell-to-cell connection and enhancement of force development

Journal of Pharmacology and Experimental Therapeutics

Volumn 318, Issue 2, 2006, Pages 530-539

  Nobe, Koji ^a   Miyatake, Mari ^a   Sone, Tomoko ^a   Honda, Kazuo ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 9,11 DIDEOXY 11ALPHA,9ALPHA EPOXYMETHANO PROSTAGLANDIN F2ALPHA; ACTIN; CADHERIN; DIACYLGLYCEROL KINASE; GLUCOSE; PROTEIN KINASE C; RHO KINASE; THROMBOXANE A2 DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL FUNCTION; CELL INTERACTION; CELL MEMBRANE PERMEABILITY; CELL STRUCTURE; CONTROLLED STUDY; COW; DIABETES MELLITUS; ENZYME INHIBITION; GLUCOSE BLOOD LEVEL; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE CONTRACTILITY; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ACETOPHENONES; ANIMALS; BENZOPYRANS; BENZOQUINONES; CADHERINS; CALCIUM; CAPILLARY PERMEABILITY; CATTLE; CELL COMMUNICATION; CELLS, CULTURED; EGTAZIC ACID; ENDOTHELIAL CELLS; ENZYME INHIBITORS; EXTRACELLULAR SPACE; GLUCOSE; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; ISOMETRIC CONTRACTION; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; VASOCONSTRICTOR AGENTS;

EID: 33745942832     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.105015     Document Type: Article

References (32)

1. Berk BC, Corson MA, Peterson TE, and Tseng H (1995) Protein kinases as mediators of fluid shear stress stimulated signal transduction in endothelial cells: a hypothesis for calcium-dependent and calcium-independent events activated by flow. J Biomech 28:1439-1450.
2. Calles-Escandon J and Cipolla M (2001) Diabetes and endothelial dysfunction: a clinical perspective. Endocr Rev 22:36-52.
3. Ceriello A (2003) The possible role of postprandial hyperglycaemia in the pathogenesis of diabetic complications. Diabetologia 46 (Suppl 1):M9-16.
4. Chang SW and Ohara N (1993) Increased pulmonary vascular permeability in rats with biliary cirrhosis: role of thromboxane A2. Am J Physiol 264:L245-L252.
5. Cohen RA (2005) Role of nitric oxide in diabetic complications. Am J Ther 12:499-502.
6. 2+-nitric oxide signalling pathway. Clin Exp Pharmacol Physiol 32:771-776.
7. Davi G, Catalano I, Averna M, Notarbartolo A, Strano A, Ciabattoni G, and Patrono C (1990) Thromboxane biosynthesis and platelet function in type II diabetes mellitus. N Engl J Med 322:1769-1774.
8. De Witt BJ, Kaye AD, Ibrahim IN, Bivalacqua TJ, D'Souza FM, Banister RE, Arif AS, and Nossaman BD (2001) Effects of PKC isozyme inhibitors on constrictor responses in the feline pulmonary vascular bed. Am J Physiol 280:L50-L57.
9. 2/M. J Cell Sci 115:983-989.
10. Imai-Sasaki R, Kainoh M, Ogawa Y, Ohmori E, Asai Y, and Nakadate T (1995) Inhibition by beraprost sodium of thrombin-induced increase in endothelial macromolecular permeability. Prostaglandins Leukot Essent Fatty Acids 53:103-108.
11. Kobayashi T, Matsumoto T, and Kamata K (2005) IGF-I-induced enhancement of contractile response in organ-cultured aortae from diabetic rats is mediated by sustained thromboxane A2 release from endothelial cells. J Endocrinol 186:367-376.
12. Lee HZ, Yeh FT, and Wu CH (2004) The effect of elevated extracellular glucose on adherens junction proteins in cultured rat heart endothelial cells. Life Sci 74:2085-2096.
13. Lum H and Malik AB (1994) Regulation of vascular endothelial barrier function. Am J Physiol 267:L223-L241.
14. Marignani PA, Epand RM, and Sebaldt RJ (1996) Acyl chain dependence of diacylglycerol activation of protein kinase C activity in vitro. Biochem Biophys Res Commun 225:469-473.
15. Niedowicz DM and Daleke DL (2005) The role of oxidative stress in diabetic complications. Cell Biochem Biophys 43:289-330.
16. Nobe K, Miyatake M, Nobe H, Sakai Y, Takashima J, and Momose K (2004a) Novel diacylglycerol kinase inhibitor selectively suppressed an U46619-induced enhancement of mouse portal vein contraction under high glucose conditions. Br J Pharmacol 143:166-178.
17. 2+. Circ Res 88:1283-1290.
18. Nobe K, Sone T, Paul RJ, and Honda K (2005) Thrombin-induced force development in vascular endothelial cells: contribution to alteration of permeability mediated by calcium-dependent and -independent pathways. J Pharmacol Sci 99:252-263.
19. Nobe K, Suzuki H, Nobe H, Sakai Y, and Momose K (2003) High-glucose enhances a thromboxane A2-induced aortic contraction mediated by an alteration of phosphatidylinositol turnover. J Pharmacol Sci 92:267-282.
20. Nobe K, Suzuki H, Sakai Y, Nobe H, Paul RJ, and Momose K (2004b) Glucose-dependent enhancement of spontaneous phasic contraction is suppressed in diabetic mouse portal vein: association with diacylglycerol-protein kinase C pathway. J Pharmacol Exp Ther 309:1263-1272.
21. Ostergaard J, Hansen TK, Thiel S, and Flyvbjerg A (2005) Complement activation and diabetic vascular complications. Clin Chim Acta 361:10-19.
22. Pfister SL, Pratt PE, Kurian J, and Campbell WB (2004) Glibenclamide inhibits thromboxane-mediated vasoconstriction by thromboxane receptor blockade. Vascul Pharmacol 40:285-292.
23. Prabhakar SS (2004) Role of nitric oxide in diabetic nephropathy. Semin Nephrol 24:333-344.
24. Qaum T, Xu Q, Joussen AM, Clemens MW, Qin W, Miyamoto K, Hassessian H, Wiegand SJ, Rudge J, Yancopoulos GD, et al. (2001) VEGF-initiated blood-retinal barrier breakdown in early diabetes. Investig Ophthalmol Vis Sci 42:2408-2413.
25. Ramana KV, Friedrich B, Tammali R, West MB, Bhatnagar A, and Srivastava SK (2005) Requirement of aldose reductase for the hyperglycemic activation of protein kinase C and formation of diacylglycerol in vascular smooth muscle cells. Diabetes 54:818-829.
26. Rolo AP and Palmeira CM (2006) Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol Appl Pharmacol. 212:167-178.
27. (2+) signalling and PKCalpha activate increased endothelial permeability by disassembly of VE-cadherin junctions. J Physiol 533:433-445.
28. Santilli F, Cipollone F, Mezzetti A, and Chiarelli F (2004) The role of nitric oxide in the development of diabetic angiopathy. Horm Metab Res 36:319-335.
29. Teixeira CF, Farmer P, Laporte J, Jancar S, and Sirois P (1995) Increased permeability of bovine aortic endothelial cell monolayers in response to a thromboxane A2-mimetic. Agents Actions Suppl 45:47-52.
30. Tonshoff B, Momper R, Schweer H, Scharer K, and Seyberth HW (1992) Increased biosynthesis of vasoactive prostanoids in Schonlein-Henoch purpura. Pediatr Res 32:137-140.
31. Vouret-Craviari V, Boquet P, Pouyssegur J, and Van Obberghen-Schilling E (1998) Regulation of the actin cytoskeleton by thrombin in human endothelial cells: role of Rho proteins in endothelial barrier function. Mol Biol Cell 9:2639-2653.
32. Yu Y and Lyons TJ (2005) A lethal tetrad in diabetes: hyperglycemia, dyslipidemia, oxidative stress, and endothelial dysfunction. Am J Med Sci 330:227-232.